{"title":"COVID-19 mRNA vaccine-induced lung injury: A case report","authors":"Pauline Luczynski, K. Aboulhosn","doi":"10.1080/24745332.2022.2048979","DOIUrl":null,"url":null,"abstract":"Abstract Vaccination is the most effective method for preventing severe COVID-19 illness. With billions of people having received the COVID-19 mRNA vaccine, rare adverse events are now surfacing. We report a case of acute lung injury with concurrent inflammatory pneumonitis, pneumothorax and pulmonary emboli following mixed COVID-19 mRNA vaccination. The patient was admitted to hospital for hypoxemic respiratory failure and gradually improved clinically and radiographically after treatment with steroids. As our population is vaccinated against COVID-19, including boosters, mixed vaccination will undoubtably become more common. It will therefore be important to recognize that lung injury may be a rare but serious adverse reaction to the COVID-19 mRNA vaccine, with mixed mRNA vaccination being a possible added risk factor.","PeriodicalId":9471,"journal":{"name":"Canadian Journal of Respiratory, Critical Care, and Sleep Medicine","volume":"26 1","pages":"216 - 220"},"PeriodicalIF":1.5000,"publicationDate":"2022-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Respiratory, Critical Care, and Sleep Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/24745332.2022.2048979","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 1
Abstract
Abstract Vaccination is the most effective method for preventing severe COVID-19 illness. With billions of people having received the COVID-19 mRNA vaccine, rare adverse events are now surfacing. We report a case of acute lung injury with concurrent inflammatory pneumonitis, pneumothorax and pulmonary emboli following mixed COVID-19 mRNA vaccination. The patient was admitted to hospital for hypoxemic respiratory failure and gradually improved clinically and radiographically after treatment with steroids. As our population is vaccinated against COVID-19, including boosters, mixed vaccination will undoubtably become more common. It will therefore be important to recognize that lung injury may be a rare but serious adverse reaction to the COVID-19 mRNA vaccine, with mixed mRNA vaccination being a possible added risk factor.